Featured News

Osteoarthritis Research Society International “Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study” AbstractObjective. Approximately 30% of patients with type 2 diabetes mellitus have knee osteoarthritis. IA corticosteroids used to manage osteoarthritis pain Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study 8 hours 3 min ago.
Osteoarthritis Research Society International “IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice” Juvenile ischemic osteonecrosis (JIO) of the femoral head is one of the most serious hip disorders causing a permanent deformity of the femoral head in childhood. We recently reported that interleukin 6 (IL6) is predominantly increased in the hip synovial fluid of patients with JIO and that articula... IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice 1 day 9 hours ago.

@OARSInews “Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase… https://t.co/OPcy9qw94N About: 12 hours 2 min ago

Featured Resources

OARSI White Paper- OA as a Serious Disease

By Various

Published 4/16/2018

Patient Summary- Non Surgical Treatment of Knee Osteoarthritis

By Multiple Authors

Published 3/10/2014

About OARSI

OARSI Mission

OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment...

1120 Route 73 Suite 200
Mount Laurel, NJ, 08054
info@oarsi.org
856-642-4215

Email Alerts

To signup for our e-newsletter, please create an account. If you already have an account or are a Member of OARSI, you are already signed up to receive our e-newsletter.

Create an Account

Osteoarthritis Research Society International

Global Menu

You are here

OARSI eNews